Literature DB >> 1710160

South American snake venom proteins antigenically related to Bothrops asper myotoxins.

B Lomonte1, M F Furtado, M E Rovira, E Carmona, G Rojas, R Aymerich, J M Gutiérrez.   

Abstract

1. The presence of proteins antigenically related to Bothrops asper myotoxins in various snake venoms, mainly from South America, was investigated by using polyclonal and monoclonal antibodies. 2. Myotoxin-like components were detected in ten Bothrops venoms from South America, and in the venoms of Crotalus atrox (North America), Trimeresurus flavoviridis (Japan), and Micrurus alleni (Costa Rica). 3. Cross-reactive components detected in several Bothrops venoms show a common subunit of 15-16 kDa by sodium dodecyl sulphate-polyacrylamide gel electrophoresis, although significant charge variations are evident by immunoelectrophoresis. 4. It is concluded that proteins antigenically related to B. asper myotoxins are relatively common in the genus Bothrops and, in the light of findings discussed, are likely to possess myotoxic activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1710160

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  2 in total

1.  Effects of neutrophil depletion in the local pathological alterations and muscle regeneration in mice injected with Bothrops jararaca snake venom.

Authors:  Catarina F P Teixeira; Fernando Chaves; Stella R Zamunér; Cristina M Fernandes; Juliana P Zuliani; María Alice Cruz-Hofling; Irene Fernandes; José María Gutiérrez
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

2.  Alkylation of histidine residues of Bothrops jararacussu venom proteins and isolated phospholipases A2: a biotechnological tool to improve the production of antibodies.

Authors:  C L S Guimarães; S H Andrião-Escarso; L S Moreira-Dill; B M A Carvalho; D P Marchi-Salvador; N A Santos-Filho; C A H Fernandes; M R M Fontes; J R Giglio; B Barraviera; J P Zuliani; C F C Fernandes; L A Calderón; R G Stábeli; F Albericio; S L da Silva; A M Soares
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.